Researchers combine two drugs to create new cancer treatment

28 February 2012

A new cancer treatment could be on the horizon, in a development which involves combining two existing drugs for the disease.

Scientists at the Vall d'Hebron Institute of Oncology (VHIO) have carried out a study which demonstrates that two drugs which have stopped being effective can improve their efficacy when mixed together.

On top of this, the innovative treatment has been found to break down the resistance that the body puts up against the effects of each drug.

As a result, medical professionals may be able to use the study to create a new way of tending to clinically advanced metastatic tumours.

Lead author of the research Dr Javier Cortes, head of the breast cancer programme at the VHIO, stated: "The novelty factor does not lie in the combination itself, but in the combination of two drugs that had already been administered in the past and had each failed."

According to Cancer Research UK, more than 48,000 people were diagnosed with breast cancer in the UK during 2008 – with the disease accounting for 16 per cent of all cancer cases in the country.

Posted by Jeanette Royston

Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)